Venus Concept (VERO) Stock Price, News & Analysis

Company Overview

Venus Concept Ltd. (NASDAQ: VERO) is a Canada-based medical aesthetic device company that designs, develops and commercializes minimally and noninvasive solutions for face and body rejuvenation. The company’s core product portfolio leverages proprietary technologies such as multi-polar radio frequency, pulsed electromagnetic fields and intense pulsed light to offer treatments for skin tightening, body contouring, wrinkle reduction and vascular lesion removal.

Among its flagship offerings are the Venus Legacy platform, which combines radio frequency and electromagnetic pulses for cellulite reduction and circumferential reduction, and the Venus Versa system, a multi-application device for facial revitalization, acne treatment, hair removal and photorejuvenation. Venus Concept continually invests in research and development to enhance treatment efficacy, patient comfort and practice efficiencies for aesthetic clinics.

The company markets its products worldwide through a combination of direct sales teams and distribution partners, serving markets across North America, Europe, Asia Pacific and the Middle East. Venus Concept’s global footprint includes offices in Toronto, New York and Munich, supported by a network of certified training centers and clinical educators to ensure optimal operator proficiency and patient outcomes.

Founded in 2010, Venus Concept transitioned into a publicly traded company in 2014 to fuel its expansion into new geographies and broaden its product suite. Under the leadership of Chief Executive Officer Orit Rahamim and Chief Financial Officer Dan Lee, the company has focused on strategic investments in technology innovation, clinical evidence generation and operational scalability to strengthen its position in the competitive medical aesthetics industry.

Key Stats

• Today's Range: $2.36 to $2.49
• 50-Day Range: $2.18 to $2.69
• 52-Week Range: $2.10 to $14.50
• Volume: 20,063 shs
• Average Volume: 852,858 shs
• Market Capitalization: $3.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Venus Concept Stock Analysis - MarketRank™

Venus Concept scored higher than 22% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Venus Concept.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Venus Concept is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Venus Concept is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Venus Concept has a P/B Ratio of 0.55. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.50% of the float of Venus Concept has been sold short.

Short Interest Ratio / Days to Cover

Venus Concept has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Venus Concept has recently increased by 54.79%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Venus Concept does not currently pay a dividend.

Dividend Growth

Venus Concept does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

5.50% of the float of Venus Concept has been sold short.

Short Interest Ratio / Days to Cover

Venus Concept has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Venus Concept has recently increased by 54.79%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.96

News Sentiment

Venus Concept has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Venus Concept this week, compared to 1 article on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Venus Concept insiders have not sold or bought any company stock.

Percentage Held by Insiders

28.04% of the stock of Venus Concept is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

87.41% of the stock of Venus Concept is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

VERO Stock Analysis - Frequently Asked Questions

How have VERO shares performed this year?

Venus Concept's stock was trading at $4.1415 on January 1st, 2025. Since then, VERO stock has decreased by 42.4% and is now trading at $2.3850.

How were Venus Concept's earnings last quarter?

Venus Concept Inc. (NASDAQ:VERO) announced its quarterly earnings data on Thursday, August, 14th. The company reported ($8.03) EPS for the quarter, beating analysts' consensus estimates of ($9.72) by $1.69. The company had revenue of $15.69 million for the quarter, compared to analysts' expectations of $14.01 million. Venus Concept had a negative net margin of 68.77% and a negative trailing twelve-month return on equity of 871.77%.
Read the conference call transcript.

When did Venus Concept's stock split?

Venus Concept shares reverse split on the morning of Tuesday, March 4th 2025.The 1-11 reverse split was announced on Friday, February 14th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 3rd 2025. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

How do I buy shares of Venus Concept?

Shares of VERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Venus Concept own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Venus Concept investors own include Tesla (TSLA), Agenus (AGEN), Cisco Systems (CSCO), Taiwan Semiconductor Manufacturing (TSM), Intel (INTC), Pfizer (PFE) and

Company Calendar

• Last Earnings: 8/14/2025
• Today: 10/15/2025
• Next Earnings (Estimated): 11/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:VERO
• CIK: 1409269
• Web: www.venusconcept.com
• Phone: (888) 907-0115
• Fax: N/A
• Employees: 410
• Year Founded: 1977

Profitability

• EPS (Trailing Twelve Months): ($50.78)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$47 million
• Net Margins: -68.77%
• Pretax Margin: -69.32%
• Return on Equity: -871.77%
• Return on Assets: -61.92%

Debt

• Debt-to-Equity Ratio: 5.72
• Current Ratio: 1.10
• Quick Ratio: 0.71

Sales & Book Value

• Annual Sales: $64.83 million
• Price / Sales: 0.05
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.30 per share
• Price / Book: 0.56

Miscellaneous

• Outstanding Shares: 1,420,000
• Free Float: 1,025,000
• Market Cap: $3.44 million
• Optionable: Not Optionable
• Beta: 0.05